Cargando…

Parálisis de Bell secundaria a vacuna para covid-19 Pfizer: reporte de caso

BACKGROUND: BNT162b2 (Pfizer-BioNTech) is a nucleoside-modified mRNA vaccine formulated with lipid nanoparticles for the prevention of COVID-19 disease caused by SARS-CoV-2 infection. In early December 2020, BNT162b2 received an emergency use authorization, initial efficacy and safety data have been...

Descripción completa

Detalles Bibliográficos
Autor principal: González-Enríquez, José Octavio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Mexicano del Seguro Social 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396063/
https://www.ncbi.nlm.nih.gov/pubmed/35759681

Ejemplares similares